Senile Systemic Amyloidosis Presenting With Heart Failure
Top Cited Papers
Open Access
- 27 June 2005
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 165 (12) , 1425-1429
- https://doi.org/10.1001/archinte.165.12.1425
Abstract
Research from JAMA Internal Medicine — Senile Systemic Amyloidosis Presenting With Heart Failure — A Comparison With Light Chain–Associated AmyloidosisKeywords
This publication has 13 references indexed in Scilit:
- High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year StudyAnnals of Internal Medicine, 2004
- High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trialBone Marrow Transplantation, 2003
- Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy.Amyloid, 2003
- Tabulation of human transthyretin (TTR) variants, 2003Amyloid, 2003
- Characterization of Transthyretin Variants in Familial Transthyretin Amyloidosis by Mass Spectrometric Peptide Mapping and DNA Sequence AnalysisAnalytical Chemistry, 2002
- A simple screening test for variant transthyretins associated with familial transthyretin amyloidosis using isoelectric focusingBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1998
- The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvementQJM: An International Journal of Medicine, 1998
- The premortem recognition of systemic senile amyloidosis with cardiac involvementThe American Journal of Medicine, 1996
- Fibril in senile systemic amyloidosis is derived from normal transthyretin.Proceedings of the National Academy of Sciences, 1990
- Frequency and distribution of senile cardiovascular amyloidThe American Journal of Medicine, 1983